The drug — part of a class of medicines known as JAK inhibitors — is the first approved treatment for alopecia areata.
baricitinib, a once-a-day pill developed by the drugmaker Eli Lilly to treat alopecia areata, an autoimmune disease that triggers sudden hair loss. The drug was originally approved by the FDA in 2018 to treat rheumatoid arthritis.
People with the autoimmune disease can experience hair loss anywhere on their body, including around the scalp, eyebrows and eyelashes, according to the , involving a total of 1,200 patients with severe alopecia areata, found that about 40 percent of people who received a daily 4-milligram dose of the drug regrew all or almost all of their hair after 36 weeks.That compares to the about 20 percent of people who received a lower 2-milligram dose of the drug and less than 6 percent of the people in the placebo group.The drug is a breakthrough for people with the autoimmune disorder, said Dr.
Dr. Luis Garza, a dermatologist at the Johns Hopkins University School of Medicine who treats people with alopecia, said he’s had patients quit their jobs or avoid going out in public altogether over the stress of losing their hair.Up until now, there weren’t many options for people with the condition: They often relied on steroid injections or unproven creams in an attempt to reverse the condition, Garza, who researches hair loss, said.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA approves first alopecia treatment for condition that causes sudden hair lossThe drug — part of a class of medicines known as JAK inhibitors — is the first approved treatment for alopecia areata.
Consulte Mais informação »
FDA Approves First Drug to Treat Hair Loss Caused by Severe AlopeciaThe FDA on Monday approved the first-ever treatment for alopecia areata, an autoimmune disorder that causes hair loss and was thrown into the spotlight after actor Will Smith slapped comedian Chris Rock at the Oscars.
Consulte Mais informação »
FDA approves alopecia drug that restores hair growthAbout 40% of patients who took the drug had total or nearly-complete hair regrowth after 36 weeks.
Consulte Mais informação »
The FDA Just Approved The First Oral Tablet For Treating Severe Alopecia AreataThe Food and Drug Administration on Monday approved a drug called baricitinib as the first oral tablet for treating severe alopecia areata, an autoimmune disorder affecting more than 300,000 people in the United States every year.
Consulte Mais informação »